Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1447972-26-0

Post Buying Request

1447972-26-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1447972-26-0 Usage

General Description

(S)-Methyl morpholine-3-carboxylate hydrochloride is a chemical compound that is used in the pharmaceutical industry as an intermediate in the synthesis of various drugs. It is also utilized in the production of agrochemicals, dyes, and other organic compounds. (S)-Methyl morpholine-3-carboxylate hydrochloride is a salt form of (S)-Methyl morpholine-3-carboxylate, which is an organic compound belonging to the morpholine family. It is a highly versatile chemical with a wide range of applications in different industries. However, it should be handled with care due to its potential hazardous properties, and proper safety measures should be observed during its handling and storage.

Check Digit Verification of cas no

The CAS Registry Mumber 1447972-26-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,7,9,7 and 2 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1447972-26:
(9*1)+(8*4)+(7*4)+(6*7)+(5*9)+(4*7)+(3*2)+(2*2)+(1*6)=200
200 % 10 = 0
So 1447972-26-0 is a valid CAS Registry Number.

1447972-26-0Downstream Products

1447972-26-0Relevant articles and documents

HETEROCYCLE CARBOXAMIDE DERIVATIVES HAVING ADAMANTYL GROUP, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT

-

Paragraph 0271-0274, (2017/08/18)

The present invention relates to a heterocyclic carboxamide derivative having an adamantyl group represented by chemical formula 1 which inhibits the activity of 11andbeta;-hydroxysteroid dehydrogenase type 1 (11andbeta;-HSD1), a prodrug of the same, a solvate of the same, a stereoisomer or a pharmaceutically acceptable salt of the same, a preparation method of the same, and a pharmaceutical composition comprising the same as an active ingredient. In the chemical formula 1, W, X, R_1, R_2, L, a, and b are as defined in the specification of the present invention.COPYRIGHT KIPO 2017

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1447972-26-0